319 related articles for article (PubMed ID: 30566676)
1. Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content.
Utzschneider KM; Kahn SE; Polidori DC
J Clin Endocrinol Metab; 2019 May; 104(5):1855-1865. PubMed ID: 30566676
[TBL] [Abstract][Full Text] [Related]
2. Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease.
Poulsen MK; Nellemann B; Stødkilde-Jørgensen H; Pedersen SB; Grønbæk H; Nielsen S
J Clin Endocrinol Metab; 2016 Apr; 101(4):1637-46. PubMed ID: 26829441
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
4. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
5. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
[TBL] [Abstract][Full Text] [Related]
6. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans.
Kratz M; Marcovina S; Nelson JE; Yeh MM; Kowdley KV; Callahan HS; Song X; Di C; Utzschneider KM
Am J Clin Nutr; 2014 Jun; 99(6):1385-96. PubMed ID: 24740208
[TBL] [Abstract][Full Text] [Related]
7. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
[TBL] [Abstract][Full Text] [Related]
9. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
Goto T; Onuma T; Takebe K; Kral JG
Int J Obes Relat Metab Disord; 1995 Dec; 19(12):841-5. PubMed ID: 8963349
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
[TBL] [Abstract][Full Text] [Related]
11. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
[TBL] [Abstract][Full Text] [Related]
12. [Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].
Chen L; Xiang KS; Jia WP; Lu JX; Bao YQ; Lu HJ
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1456-9. PubMed ID: 16061021
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
14. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
15. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
Smith GI; Polidori DC; Yoshino M; Kearney ML; Patterson BW; Mittendorfer B; Klein S
J Clin Invest; 2020 Jun; 130(6):3305-3314. PubMed ID: 32191646
[TBL] [Abstract][Full Text] [Related]
16. Effect of liver fat on insulin clearance.
Kotronen A; Vehkavaara S; Seppälä-Lindroos A; Bergholm R; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1709-15. PubMed ID: 17895288
[TBL] [Abstract][Full Text] [Related]
17. Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease.
Kato K; Takamura T; Takeshita Y; Ryu Y; Misu H; Ota T; Tokuyama K; Nagasaka S; Matsuhisa M; Matsui O; Kaneko S
PLoS One; 2014; 9(3):e92170. PubMed ID: 24651470
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Tripathy D; Jenkinson C; Folli F
Diabetes Care; 2015 Aug; 38(8):1509-17. PubMed ID: 26084344
[TBL] [Abstract][Full Text] [Related]
19. β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.
Mey JT; Erickson ML; Axelrod CL; King WT; Flask CA; McCullough AJ; Kirwan JP
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E187-E195. PubMed ID: 32396388
[TBL] [Abstract][Full Text] [Related]
20. Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.
Llauradó G; Sevastianova K; Sädevirta S; Hakkarainen A; Lundbom N; Orho-Melander M; Groop PH; Forsblom C; Yki-Järvinen H
J Clin Endocrinol Metab; 2015 Feb; 100(2):607-16. PubMed ID: 25405502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]